Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives
Abstract Glioblastoma (GBM) is a highly aggressive adult brain cancer, characterised by poor prognosis and a dismal five-year survival rate. Despite significant knowledge gains in tumour biology, meaningful advances in patient survival remain elusive. The field of neuro-oncology faces many disease o...
I tiakina i:
| Ngā kaituhi matua: | , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2025-01-01
|
| Rangatū: | Acta Neuropathologica Communications |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s40478-025-01928-x |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|